| Health / Medical Topics |
CMV N495 Peptide
A peptide derived from cytomegalovirus (CMV) internal matrix protein pp65. CMV pp65 peptide antigen is used in recombinant vaccinia virus as an HLA-A-restricted epitope to produce vaccines and specific CD8+ and CD4+ cell responses against CMV infection, a serious complication of allogeneic bone marrow transplantation (BMT). In BMT, CMV infection may be prevented by passive immunization with donor-derived CMV-pp65-specific T-cell clones if provided early post-BMT. (NCI Thesaurus)
YOU MAY ALSO LIKE
A virus that may be carried in an inactive state for life by healthy individuals. It is a cause of severe pneumonia…
A condition that may occur in patients who have had surgery to remove a tumor in certain parts of the brain, including…
A slowly progressing type of myelodysplastic/myeloproliferative disease in which too many myelomonocytes (a type of white blood cell) are in the bone…
A slowly progressing disease in which too many white blood cells (not lymphocytes) are made in the bone marrow. Also called chronic…
Human CMKLR1 wild-type allele is located in the vicinity of 12q24.1 and is approximately 48 kb in length. This allele, which encodes…
This gene plays a role in G protein-coupled receptor signal transduction; however, its exact function is unknown.
